Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nipro ( (JP:8086) ) has provided an announcement.
Nipro Corporation will establish a wholly owned regional headquarters subsidiary in Singapore, Nipro Asia Pacific Group Pte Ltd (tentative name), to oversee its group companies in the Asia-Pacific region. As part of this reorganization, Nipro will contribute the shares of its existing Singapore-based consolidated subsidiary, Nipro Asia Pte Ltd, which sells medical devices, to the new entity as a contribution in kind, with additional transfers of other group companies to be decided based on tax and other considerations. The move is aimed at strengthening global governance and compliance, enhancing regional headquarters functions, enabling faster responses to local market needs, promoting local production for local consumption, and achieving financial independence in the Asia-Pacific region, with the company currently reviewing the impact on its business performance.
The most recent analyst rating on (JP:8086) stock is a Hold with a Yen1593.00 price target. To see the full list of analyst forecasts on Nipro stock, see the JP:8086 Stock Forecast page.
More about Nipro
Nipro Corporation is a Japan-based medical devices and healthcare company that operates globally, with a strong presence in the Asia-Pacific region. Its businesses include the manufacture and sale of medical devices and related products, and it manages a network of group companies to support regional sales and operations.
Average Trading Volume: 501,924
Technical Sentiment Signal: Buy
Current Market Cap: Yen242B
Learn more about 8086 stock on TipRanks’ Stock Analysis page.

